Tissue Responses to Shiga Toxin in Human Intestinal Organoids
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Mar 2020 · 1 min read
In brief
In brief
This study uses human stem cell-derived intestinal organoids to model Shiga toxin pathogenesis, revealing complex tissue responses including epithelial-mesenchymal cross-talk, maintained barrier function despite cell death, and toxin translocation. The organoid system overcomes limitations of murine models and simple cell cultures for studying E. coli O157:H7 infection mechanisms.
Written by the GCMD Library team from the article.
Statements in this article
Shiga toxin-producing Escherichia coli (such as O157:H7) infection produces bloody diarrhea.
Shiga toxin inhibits protein synthesis and causes the life-threatening systemic complication of hemolytic uremic syndrome.
The murine intestinal tract is resistant to O157:H7 and Shiga toxin.
Human cells in culture fail to model the complex tissue responses to intestinal injury.
Human intestinal organoids contain a lumen with a single layer of differentiated epithelium surrounded by mesenchymal cells.
Enteroids derived from multipotent intestinal stem cells only contain epithelium.
Shiga toxin induced necrosis and apoptotic death in both epithelial and mesenchymal cells.
Cellular proliferation and wound repair responses that require protein synthesis were observed after Shiga toxin exposure.
Epithelial barrier function was maintained even after epithelial cell death was seen.
Apical to basolateral translocation of Shiga toxin was observed.
Tissue cross-talk in which mesenchymal cell damage caused epithelial cell damage was observed.
Shiga toxin induced mesenchymal expression of the epithelial marker.
